AU2001292481A1 - Promoter sequences - Google Patents

Promoter sequences

Info

Publication number
AU2001292481A1
AU2001292481A1 AU2001292481A AU9248101A AU2001292481A1 AU 2001292481 A1 AU2001292481 A1 AU 2001292481A1 AU 2001292481 A AU2001292481 A AU 2001292481A AU 9248101 A AU9248101 A AU 9248101A AU 2001292481 A1 AU2001292481 A1 AU 2001292481A1
Authority
AU
Australia
Prior art keywords
foxc2
nucleotide sequence
nucleic acid
enhancer
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292481A
Other languages
English (en)
Inventor
Sven Enerback
Katarina Krook
Lena Rondahl
Wyeth W. Wasserman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LeanGene AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003435A external-priority patent/SE0003435D0/xx
Priority claimed from SE0004102A external-priority patent/SE0004102D0/xx
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of AU2001292481A1 publication Critical patent/AU2001292481A1/en
Assigned to LEANGENE AB reassignment LEANGENE AB Request for Assignment Assignors: BIOVITRUM AB
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Seasonings (AREA)
AU2001292481A 2000-09-26 2001-09-26 Promoter sequences Abandoned AU2001292481A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0003435A SE0003435D0 (sv) 2000-09-26 2000-09-26 Promoter sequences
SE0003435 2000-09-26
US23889700P 2000-10-10 2000-10-10
US60238897 2000-10-10
SE0004102A SE0004102D0 (sv) 2000-11-09 2000-11-09 Promoter sequences II
SE0004102 2000-11-09
PCT/SE2001/002098 WO2002027008A1 (fr) 2000-09-26 2001-09-26 Sequences de promoteurs

Publications (1)

Publication Number Publication Date
AU2001292481A1 true AU2001292481A1 (en) 2002-04-08

Family

ID=27354602

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292481A Abandoned AU2001292481A1 (en) 2000-09-26 2001-09-26 Promoter sequences

Country Status (5)

Country Link
EP (1) EP1320623A1 (fr)
JP (1) JP2004510417A (fr)
AU (1) AU2001292481A1 (fr)
CA (1) CA2421620A1 (fr)
WO (1) WO2002027008A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538930A (ja) * 2002-01-29 2005-12-22 リーンジーン・アクチボラゲット ヒトｆｏｘｃ２タンパク質およびｆｏｘｃ−２相互作用タンパク質の複合体
WO2005035793A2 (fr) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Marqueurs et haplotypes de cckar associes a des etats d'excedent de poids
SE0400489D0 (sv) * 2004-02-27 2004-02-27 Biovitrum Ab Therapeutic proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701963D0 (sv) * 1997-05-26 1997-05-26 Pharmacia & Upjohn Ab Novel transcription factor
WO2001060853A1 (fr) * 2000-02-18 2001-08-23 Biovitrum Ab Modele animal transgenique destine a l'expression du gene foxc2 pour traiter l'obesite

Also Published As

Publication number Publication date
WO2002027008A1 (fr) 2002-04-04
EP1320623A1 (fr) 2003-06-25
CA2421620A1 (fr) 2002-04-04
JP2004510417A (ja) 2004-04-08

Similar Documents

Publication Publication Date Title
Millar et al. Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia
Koch et al. Comparative genomics and regulatory evolution: conservation and function of the Chs and Apetala3 promoters
KR101902526B1 (ko) 특이적 프로모터의 작제 방법
Scohy et al. Identification of KLF13 and KLF14 (SP6), novel members of the SP/XKLF transcription factor family
Seroussi et al. Characterization of the human NIPSNAP1 gene from 22q12: a member of a novel gene family
KR100961722B1 (ko) 징크 핑거 도메인 라이브러리
Pan et al. An intronic polyadenylation site in human and mouse CstF-77 genes suggests an evolutionarily conserved regulatory mechanism
Wei et al. Identification of a new sea urchin ets protein, SpEts4, by yeast one-hybrid screening with the hatching enzyme promoter
CN108893539B (zh) 猪肉质性状相关的circRNA及其应用
Henderson et al. c-Jun inhibits transcriptional activation by the insulin enhancer, and the insulin control element is the target of control
Bachman et al. Phylogenetic footprinting of the human cytochrome c oxidase subunit VB promoter
der Maur et al. Characterization of the mouse gene for the heavy metal-responsive transcription factor MTF-1
AU2001292481A1 (en) Promoter sequences
Cai et al. hnulp1, a basic helix-loop-helix protein with a novel transcriptional repressive domain, inhibits transcriptional activity of serum response factor
US20050244842A1 (en) Promoter sequences
Weaver et al. Genomic characterization of a testis-specific TFIIS (TCEA2) gene
Kasper et al. Different structural organization of the encephalopsin gene in man and mouse
Illarionova et al. Only those genes of the KIAA1245 gene subfamily that contain HERV (K) LTRs in their introns are transcriptionally active
Smits et al. Molecular cloning and characterization of the mouse Ecm1 gene and its 5′ regulatory sequences
Pi et al. A novel human SCAN/(Cys) 2 (His) 2 zinc-finger transcription factor ZNF323 in early human embryonic development
US10711279B2 (en) Promoter sequences
Carlsson et al. Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C
Ou et al. ZNF328, a novel human zinc-finger protein, suppresses transcriptional activities of SRE and AP-1
Bates et al. Structural and functional characterization of the mouse Hlx homeobox gene
Ashworth Two acetyl-CoA acetyltransferase genes located in the t-complex region of mouse chromosome 17 partially overlap the Tcp-1 and Tcp-1 x genes

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted